Aviana Sinar Abadi Tbk. vs Merck Tbk. — how do they compare? Aviana Sinar Abadi Tbk. trades at Rp294 (market cap 1.66T, 124.08M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Aviana Sinar Abadi Tbk. and Merck Tbk. are close in size by market cap, and Aviana Sinar Abadi Tbk. is more actively traded (124.08M versus 37.6K). Which is the better fit depends on your goals.
| IRSX | MERK | |
|---|---|---|
Market Cap | 1.66T | 1.7T |
Volume | 124.08M | 37.6K |
Lot | 1.24M | 376 |
Turnover | 35.62B | 144.47M |
Average Price | 287.1 | 3,842.23 |
Value | 35.62B | 144.47M |
Indicative Equilibrium Price | 294 | 3,840 |
Indicative Equilibrium Volume | 14.62K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Aviana Sinar Abadi Tbk (the Company) was established on December 17, 2013 based on Notarial Deed No. 15 of Isadora, S.H., M.Kn., notary in Jakarta. The Company started its commercial operations in 2013.
Read more on IRSX →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →